Cyclooxygenase-2 (Cox-2) Expression in Lymphomas

Reference

• Evans, L.S. and Hancock, B.W. (2003) "Non-Hodgkin lymphoma", Lancet, 362, 139–146.
   PubMed Web of Science ®Google Scholar
• Shipp, M.A., Harrington, D.L. and Anderson, J. (1993) "Develop-ment of practice model for aggressive lymphoma", N. EngL J. Med., 329, 987–994.
   Google Scholar
• Dubois, R.N., Arramson, S.B., Crofffird, L., et al. (1998) "Cyclooxygenase in biology and disease", FASEB J., 12, 1063 — 1073.
   Google Scholar
• Steinbach, G., Lynch, P.M., Phillips, R., et al. (2000) "The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis", N. EngL J. Med., 342, 1946–1952.
   Web of Science ®Google Scholar
• Thun, M.J., Namboodiri, M.M. and Heath, C.W.J. (1991) "Aspirin use and reduced risk of fatal colon cancer", N. EngL J. Med., 325, 1593 —1596.
   Web of Science ®Google Scholar
• Rosenberg, L., Louik, C. and Shapiro, S. (1998) "Nonsteroidal antiinflammatory drug use and reduced risk of large bowel carcinoma", Cancer, 82, 2326–2333.
   Google Scholar
• Williams, CS., Watson, A., Sheng, H., et al. (2000) "Celecoxib prevents tumor growth in vitro without toxicity to normal gut: lack of correlation between in vitro and in vivo models", Cancer Res., 60, 6045–6051.
   PubMed Web of Science ®Google Scholar
• Petersen, C., Petersen, S., Milas, L., et al. (2000) "Enhancement of intrinsic tumor cell radiosensitivity induced by a selective cycloox-ygenase-2 inhibitor", Clin. Cancer Res., 6, 2513–2520.
   Web of Science ®Google Scholar
• Marrogi, A., Pass, HI., Khan, M., et al. (2000) "Human mesothelioma samples overexpress both cyclooxygenase-2 (Cox-2) and inducible nitric oxide synthase (N052): In vitro antiprolifera-tive effects of a Cox-2 inhibitor", Cancer Res., 60, 3696— 3700.
   Google Scholar
• Marrogi, A., Travis, W.D., Welsh, J.A., et al. (2000) "Nitric oxide synthase, cyclooxygenase-2, and vascular endothelial growth factor in the angiogenesis of non-small cell lung carcinoma", Clin. Cancer Res., 6, 4739–4744.
   Web of Science ®Google Scholar
• Altorlci, N.K., Keresztes, R.S., Port, J.L., etal. (2003) "Celecoxib, a selective cyclooxygenase-2 inhibitor, enhances the response to preoperative paclitaxel and carboplatin in early stage non-small cell lung cancer", J. Clin. OncoL, 21, 2645–2650.
   PubMed Web of Science ®Google Scholar
• Uefuji, K., Ichikura, T. and Mocllizulci, H. (2000) "Cyclooxygen-ase-2 expression is related to prostaglandin biosynthesis and angiogenesis in human gastric cancer", Clin. Cancer Res., 6, 135 — 138.
   Web of Science ®Google Scholar
• Cheson, B.D., Horning, Si., Coiffier, B., etal. (1999) "Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas", J. Clin. OncoL, 17, 1244–1253.
   PubMed Web of Science ®Google Scholar
• Gately, S. and Kerbel, R. (2003) "Therapeutic potential of selective cyclooxygenase-2 inhibitors in the management of tumor angiogen-esis", Frog. Exp. Tumor Res., 37, 179–192.
   PubMed Web of Science ®Google Scholar
• Tsujii, M., Kawano, S. and Dubois, R.N. (1997) "Cyclooxgenase-2 expression in human colon cancer cells increases metastatic potential", Proc. Natl. Acad. Sci. USA, 94, 3336— 3340.
   PubMed Web of Science ®Google Scholar
• Hwang, D., Scollard, D., Byrne, J. and Levine, E. (1998) "Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer", J. Natl. Cancer Inst., 90, 455–460.
   Google Scholar
• Uefuji, K., Ichikura, T., Mochizulci, H. and Shinomiya, N. (1998) "Expression of cyclooxygenase-2 protein in gastric adenocarcino-ma", J. Surg. OncoL, 69, 168–172.
   Web of Science ®Google Scholar
• Eberhart, C.E., Coffey, R.J., Radhika, A., et al. (1994) "Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas", Gastroenterology, 107(4), 1183 — 1188.
   PubMed Web of Science ®Google Scholar
• Tsujii, M., Kawano, S., Tsujii, S., et al. (1998) "Cyclooxygenase regulates angiogenesis induced by colon cancer cells", Cell, 93(5), 705–716.
   PubMed Web of Science ®Google Scholar
• Bellosillo, B., Pique, M., Barragan, M. et al. (1998) "Aspirin and salicylate induce apoptosis and activation of caspases in B-cell chronic lymphocytic leukemia cells", Blood, 92(4), 1406–1414.
   PubMed Web of Science ®Google Scholar
• Klampfer, L., Cammenga, J., Wisniewslci, H.G. and Nimer, S.D. (1999) "Sodyum salicylate activates caspase and induces apoptosis of myeloid leukemia cell lines", Blood, 93(7), 2386–2394.
   PubMed Web of Science ®Google Scholar
• Graf, B,A., Nazarenko, D.A., Borrello, M.A., et al. (1999) "Biphenotypic B/macrophage cells express cox-1 and up-regulate cox-2 expression and prostaglandin E2 production in response to pro-inflammatory signals", Eur. J. ImmunoL, 29, 3793–3803.
   PubMed Web of Science ®Google Scholar
• Biederbeck, A.B., Holly, E.A., Sturkenboom, M., et al. (2003) "Prescription medications associated with a decreased risk of non-Hodgkin's lymphoma", Am. J. EpidemioL, 157, 510–516.
   Web of Science ®Google Scholar
• Liu, X.H., Yao, S., Kirschenbaum, A. and Levine, A.C. (1998) "N5398, a selective cyclooxygenase-2 inhibitor, induces apoptosis and down-regulates bc1-2 expression in LNCaP cells", Cancer Res., 58(19), 4245–4249.
   PubMed Web of Science ®Google Scholar
• Dinarello, C.A. and Bunn, P.A. (1997) "Fever", Semin. OncoL, 24(3), 288–298.
   Google Scholar
• Foss, H.D., Aravjo, I., Demel, G., et al. (1997) "Expression of vascular endothelial growth factor in lymphomas and Castleman disease", J. Pathol., 183, 44–50.
   PubMed Web of Science ®Google Scholar
• List, A.F. (2001) "Vascular endothelial growth factor signaling pathway as an emerging target in hematological malignancies", Oncologist, 6\(suppl 5), 24–31.
   PubMed Web of Science ®Google Scholar
• Hazar, B., Paydas, S., Zorludemir, S., et al. (2003) "Prognostic significance of microvessel density and vascular endothelial growth factor (VEGF) expression in non-Hodgkin's lymphoma", Leuk. Lymphoma, 44(12), 2089–2093.
   PubMed Web of Science ®Google Scholar
• Williams, CS., Tsujii, M., Reese, J., et al. (2000) "Host cyclooxygenase-2 modulates carcinoma growth", J. Clin. Invest., 105, 1589–1594.
   Google Scholar
• Konturek, P.C., Konturek, Si., Pierzchalslci, P., et al. (2002) "Gastric MALT-lymphoma, gastrin and cyclooxygenase", Acta Gastroenterol. Belg. (abstract), 65(1), 17–23.
   Google Scholar